Study type: Medical/biological study (experimental study)

Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers med./bio.

Published in: Int J Pharm 2008; 351 (1-2): 271-281

Aim of study (acc. to author)

To study the impact of exposure to electromagnetic fields on the permeability of saquinavir (drug in AIDS therapy) across the blood-brain barrier. Effects of systematic parameters of electromagnetic fields (power, wave types, frequency, modulation) were especially examined.

Background/further details

Transport of anti-retroviral agents across the blood-brain barrier is of key importance for the treatment of the acquired immunodeficiency syndrome (AIDS): Saquinavir is a protease inhibitor for reducing enzymatic activity and inducing immature filial generation of HIV (anti-human immunodeficiency virus). That is, saquinavir medication generates non-infectious virus to obtain therapeutical effect in the AIDS therapy. Transport of HIV agents across the blood-brain barrier is a prerequisite for the treatment of AIDS because HIV is replicated in the brain of HIV-infected individuals.
As pharmaceutical strategy for drug delivery, saquinavir was incorporated with PBCA (polybutylcyanoacrylate), MMA-SPM (methylmethacrylate-sulfopropylmethacrylate), and SLN (solid lipid nanoparticle).

Endpoint

Exposure

Exposure Parameters
Exposure 1: 0–915 MHz
Modulation type: CW
Exposure duration: continuous for 90 min
Exposure 2: 915 MHz
Modulation type: AM
Exposure duration: continuous for 90 min
Exposure 3: 915 MHz
Modulation type: FM
Exposure duration: continuous for 90 min
Exposure 4: 915 MHz
Modulation type: CW
Exposure duration: continuous for 90 min

Exposure 1

Main characteristics
Frequency 0–915 MHz
Type
Exposure duration continuous for 90 min
Modulation
Modulation type CW
Exposure setup
Exposure source
Chamber BBB model consisted of 14-ml donor and receiver chambers with magnetic stirring at the bottom
Setup model was maintained at 37 °C by a circulated water jacket and was placed at the bottom of a cylindrical copper coil with both diameter and length of 22 cm.
Parameters
Measurand Value Type Method Mass Remarks
power 5 mW - - - -

Exposure 2

Main characteristics
Frequency 915 MHz
Type
Exposure duration continuous for 90 min
Modulation
Modulation type AM
Modulation frequency 20 MHz
Modulation depth 100 %
Additional info

sine, square, or triangle wave

Exposure setup
Exposure source
Parameters
Measurand Value Type Method Mass Remarks
power 5 mW - - - -

Exposure 3

Main characteristics
Frequency 915 MHz
Type
Exposure duration continuous for 90 min
Modulation
Modulation type FM
Modulation frequency 20 MHz
Additional info

sine or square wave, deviation 400 kHz

Exposure setup
Exposure source
Parameters
Measurand Value Type Method Mass Remarks
power 5 mW - - - -

Exposure 4

Main characteristics
Frequency 915 MHz
Type
Exposure duration continuous for 90 min
Modulation
Modulation type CW
Exposure setup
Exposure source
  • not specified
Additional info This exposure was for testing cell viability and other effects.
Parameters
Measurand Value Type Method Mass Remarks
power 5 mW - - - -
power 10 mW - - - -
power 20 mW - - - -

Exposed system:

Methods Endpoint/measurement parameters/methodology

Investigated system:

Main outcome of study (acc. to author)

High power of electromagnetic fields caused apoptosis and power of 5 mW was apposite for the investigation on human brain-microvascular endothelial cells without obvious apoptosis.
Square wave produced greater permeability than sinusoidal and triangle waves. The carrier order on permeability of saquinavir across the blood-brain barrier model under exposure was SLN>PBCA>MMA-SPM. Also, a larger frequency, modulation or depth of amplitude modulation (AM), or modulation or deviation of frequency modulation (FM) yielded a greater permeability. Besides, enhancement of permeability by AM wave was more significant than that by FM wave.
Transport behaviour of saquinavir across the blood-brain barrier model was strongly influenced by the combination of nanoparticulate PBCA, MMA-SPM, and SLN with electromagnetic field exposure. This combination would be beneficial to the clinical application to the therapy of AIDS and other brain-related diseases.

Study character:

Related articles